Related Experiment Videos
Neutrophil depletion suppresses 111In-labeled platelet accumulation in infarcted myocardium
Insights
Myocardial platelet deposition after heart attack is primarily driven by neutrophils, not platelets themselves. Reducing neutrophils significantly decreased platelet accumulation in damaged heart tissue.
Area of Science:
- Cardiovascular Research
- Hematology
- Ischemic Injury
Background:
- Platelets and neutrophils rapidly accumulate in infarcted myocardium.
- Antineutrophil agents reduce infarct size, but antiplatelet drugs do not.
- The role of neutrophils in myocardial platelet deposition is unclear.
Purpose of the Study:
- To investigate if myocardial ischemia-induced platelet deposition is secondary to neutrophil-mediated events.
- To assess the impact of neutropenia on platelet accumulation in ischemic myocardium.
Main Methods:
- Autologous 111In-labeled platelets were injected into dogs undergoing coronary artery occlusion and reperfusion.
- Radioactivity was measured in different heart regions over time.
- Neutropenia was induced using specific anti-dog neutrophil antiserum.
Main Results:
- Platelet deposition increased linearly with reperfusion time, mirroring neutrophil accumulation.
- Neutropenia significantly reduced platelet accumulation in ischemic myocardium and abolished transmural distribution.
- Neutropenia had minimal effect on ex vivo platelet aggregation.
Conclusions:
- Myocardial platelet deposition in this occlusion-reperfusion model is secondary to neutrophil-mediated events.
- Neutrophil-platelet interactions at the site of injury may influence myocardial ischemic injury progression.
Abstract:
Platelets and neutrophils accumulate rapidly in infarcted myocardium. Although antineutrophil agents reduce the size of the infarcted area, this is not observed with antiplatelet drugs. The possibility that myocardial ischemia-induced platelet deposition was secondary to a neutrophil-mediated event was assessed by injecting prostacyclin-washed autologous 111In-labeled platelets and measuring the amount of radioactivity in different regions of the heart following 90-min occlusion of the left anterior descending coronary artery followed by reperfusion for periods up to 5 h. Platelet deposition during the reperfusion phase was linear with time and similar to the time course of neutrophil accumulation. There was a transmural distribution of radioactivity across the myocardium where the "zone" between infarcted and risk regions, called the "interface," greater than infarct greater than risk greater than normal. Neutropenia (21 +/- 2% control levels), induced with specific sheep anti-dog neutrophil antiserum, had minimal effects on platelet aggregation ex vivo, but significantly reduced platelet accumulation in the ischemic myocardium following 5-h reperfusion and abolished the transmural platelet distribution. These results suggest that myocardial platelet deposition is secondary to a neutrophil-mediated event in this occlusion-reperfusion model of myocardial injury. Interactions between platelets and neutrophils at the site of tissue damage may influence the process of myocardial ischemic injury.